Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trialGeorge Maynard, Stephen M. Strittmatter, Tu Kiet T. Lam et al.|The Lancet Neurology|2023Cited by 55
Considerations and recommendations for selection and utilization of upper extremity clinical outcome assessments in human spinal cord injury trialsLinda Jones, John D. Steeves, Anne M. Bryden et al.|Spinal Cord|2017Cited by 44